ClevelandDx Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
77
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$75M
- Investors
-
7
ClevelandDx General Information
Description
Developer of a medical technology designed to detect cancer early when it can be treated and cured. The company's technology evaluates the changes to the structure of the protein biomarker and cancer diagnostics including blood-based tests for prostate, breast, and ovarian cancer, enabling healthcare providers to detect and treat cancer in its early stages.
Contact Information
Website
www.clevelanddx.comCorporate Office
- 3615 Superior Avenue
- Suite 4406A
- Cleveland, OH 44114
- United States
Corporate Office
- 3615 Superior Avenue
- Suite 4406A
- Cleveland, OH 44114
- United States
ClevelandDx Timeline
ClevelandDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series E) | 16-Jan-2024 | $75M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series D) | 22-Feb-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 09-Feb-2021 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
| 4. Early Stage VC | 12-Dec-2017 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 21-Nov-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 11-Mar-2015 | $1.98M | $1.98M | Completed | Startup | |
| 1. Spin-Off | 06-Nov-2013 | Completed | Startup |
ClevelandDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E-2 | ||||||||
| Series E-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 1,459,271 | $0.000100 | 8% | $1.57 | $1.57 | 1x | $1.57 | 2.69% |
| Series A | 2,385,244 | $0.000100 | 8% | $0.83 | $0.83 | 1x | $0.83 | 4.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ClevelandDx Comparisons
Industry
Financing
Details
ClevelandDx Competitors (19)
One of ClevelandDx’s 19 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Metamark Genetics | Formerly VC-backed | Waltham, MA | ||||
| StageZero Life Sciences | Corporation | Richmond Hill, Canada | ||||
| Novigenix | Venture Capital-Backed | Epalinges, Switzerland | ||||
| Epic Sciences | Venture Capital-Backed | San Diego, CA |
ClevelandDx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ClevelandDx Patents
ClevelandDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11796544-B1 | Partitioning systems and methods for determining multiple types of cancers | Active | 28-Oct-2021 | ||
| US-20230314439-A1 | Partitioning systems and methods for determining multiple types of cancers | Active | 28-Oct-2021 | ||
| EP-4423506-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | ||
| CA-3236536-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | ||
| US-20240011995-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | G01N33/57484 |
ClevelandDx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ClevelandDx Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novo Holdings | Corporate Venture Capital | Minority | ||
| Nottingham Unlimited Ventures | Venture Capital | Minority | ||
| Cleveland Clinic Ventures | Corporate Venture Capital | Minority | ||
| JobsOhio Growth Capital | Venture Capital | Minority | ||
| LYFE Capital | Venture Capital | Minority |
ClevelandDx FAQs
-
When was ClevelandDx founded?
ClevelandDx was founded in 2013.
-
Where is ClevelandDx headquartered?
ClevelandDx is headquartered in Cleveland, OH.
-
What is the size of ClevelandDx?
ClevelandDx has 77 total employees.
-
What industry is ClevelandDx in?
ClevelandDx’s primary industry is Diagnostic Equipment.
-
Is ClevelandDx a private or public company?
ClevelandDx is a Private company.
-
What is the current valuation of ClevelandDx?
The current valuation of ClevelandDx is .
-
What is ClevelandDx’s current revenue?
The current revenue for ClevelandDx is .
-
How much funding has ClevelandDx raised over time?
ClevelandDx has raised $112M.
-
Who are ClevelandDx’s investors?
Novo Holdings, Nottingham Unlimited Ventures, Cleveland Clinic Ventures, JobsOhio Growth Capital, and LYFE Capital are 5 of 7 investors who have invested in ClevelandDx.
-
Who are ClevelandDx’s competitors?
CirculoGene, Metamark Genetics, StageZero Life Sciences, Novigenix, and Epic Sciences are some of the 19 competitors of ClevelandDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
